Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
13.46 Down 0.46(3.30%) Apr 17, 4:00PM EDT
|After Hours : 13.35 Down 0.11 (0.82%) Apr 17, 7:53PM EDT
Get the big picture on all your investments.
Prev Close:13.92
Open:13.79
Bid:13.35 x 900
Ask:13.70 x 1000
1y Target Est:25.64
Beta:4.2
Earnings Date:May 5 - May 9 (Est.)
Day's Range:13.43 - 14.17
52wk Range:6.61 - 17.46
Volume:2,773,736
Avg Vol (3m):3,348,160
Market Cap:1.22B
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXDown 3.30%1.22B
BAXDown 0.87%39.55B
SHPGUp 0.40%27.41B

Key Statistics

Forward P/E (1 yr):27.47
P/S (ttm):180.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Mar-14) :-0.08
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback